EYE HEALTH

BRUDYMÁCULA

BRUDY MACULA has been conceived to supplement daily requirements in essential fatty acids of the Omega-3 family and of the included group of vitamins, minerals and carotenoids, such as lutein and zeaxanthin. (KEEP READING) A food supplement including nutrients that some clinical trials (AREDS1 and AREDS-22) have shown to reduce progression of the incipient Age Related Macular Degeneration (AMD), by opposing to the pathologic neovascularization process that takes place in the exudative AMD (Favio A. Rezende; Am J Ophthalmol 20143), and improving some parameters of the visual function in the Atrophic AMD  (LAST Trial4).

Box with 60 soft gelatin capsules.

Recommended PSP+VAT: 36,09 €

C.N. 158367.3

 

 

 

 

BIBLIOGRAPHIC REFERENCES:

  1. AREDS; Arch Ophthalmol. 2001; 119: 1417-1436; Report nº 20; The Relationship of Dietary Lipid Intake and Age-Related Macular Degeneration in a Case-Control Study; Arch Ophthalmol 2007;125:671-679
  2. AREDS 2 Results; Lutein Zeaxanthin and Omega-3 Fatty Acids for Age-Related Macular Degeneration. The Age-Related Eye Disease Study 2 (AREDS2) Randomized Clinical Trial; JAMA. 2013;309(19):doi:10.1001/jama.2013.4997
  3. Flavio A Rezende, et al; Omega-3 Supplementation Combined With Anti–Vascular Endothelial Growth Factor Lowers Vitreal Levels of Vascular Endothelial Growth Factor in Wet Age-Related Macular Degeneration; Am J Ophthalmol 2014;158: 1071–1078
  4. Richer Stuard P, et al; Lutein and Antioxidant Supplementation Trial ; Optometry 2004; 75(4):216-29

© 2015-2017 Brudylab  |  Riera de Sant Miquel, 3, 2º 4ª - 08006 Barcelona (Spain) - Phone number: +34 93 217 03 66  |  info@brudylab.com  | Legal Notice  |  Cookies  |   Quality policy